RyR2 NH2-terminal Mutations Associated with Cardiomyopathies Reduce the Threshold for Ca2+ Release Termination  by Tang, Yijun
Monday, February 22, 2010 303achange in heart failure (n ¼ 5, P < 0.05) but a 2305 92 % increase with iso-
prenaline treatment (n ¼ 6, P < 0.05). Basal levels of phosphorylation are thus
relatively low at RyR Ser2030, phospholamban Ser16, and troponin I Ser23/24,
and are not significantly increased in heart failure, but are substantially in-
creased by isoprenaline treatment. In contrast, the phosphorylation level at
Ser 2809 is already high and can be increased only moderately by isoprenaline.
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Inhibition of RyR2-S2814 Phosphorylation Prevents Heart Failure by
Reducing SR Ca Leak
Ralph J. van Oort, Na Li, Jonathan L. Respress, Angela DeAlmeida,
Xander H. Wehrens.
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Abnormal regulation of RyR2 by Ca2þ/calmodulin-dependent protein kinase 2
(CaMKII) has been suggested as a cause of sarcoplasmic reticulum (SR) Ca2þ
leakage and contractile dysfunction in heart failure. We hypothesized that
CaMKII phosphorylation of RyR2 is crucial for heart failure development.
We generated RyR2 knockin mice in which CaMKII phosphorylation site
S2814 was mutated to alanine (S2814A) to prevent phosphorylation. Cardiac
function and dimensions monitored by echocardiography were similar in
S2814A and WT mice up to 12 months of age. WT (n=13) and S2814A
mice (n=9) were subjected to transverse aortic constriction (TAC) to induce
pressure overload. At 8 weeks after TAC, S2814A mice displayed a similar hy-
pertrophic response and decrease in ejection fraction (EF) as WT mice. At 16
weeks after TAC, however, EF was significantly lower in WT (32.5 þ/- 3.4%)
compared to S2814A mice (43.0 þ/- 2.9%) suggesting inhibition of heart fail-
ure development in the latter. This rescue effect was further verified by a lower
lung-weight-to-tibia-length ratio and a decrease in expression levels of the car-
diac stress genes ANF and BNP in S2814A mice compared to WT mice at 16
weeks after TAC. Ca2þ imaging in cardiomyocytes, isolated from S2814A and
WT mice at 16 weeks after sham or TAC surgery, demonstrated an decreased
incidence of spontaneous SR Ca2þ release (SCR) events in S2814A (29.7% of
myocytes) compared to WT (61.3% of myocytes; P<0.01). Whereas CaMKII
inhibitor KN93 reduced the incidence of SCR events in WT to 36.1% (P<0.01
vs. WT TAC), KN93 did not have an effect of SCR in S2814A myocytes
(30.0%; P=NS vs. S2814A TAC). Together, our results demonstrate that block-
ing CaMKII phosphorylation of RyR2 prevents SR Ca2þ leak, and inhibits or
delays the progression to congestive heart failure in S2814A mice.
1579-Pos
Luminal Regulation of Single RyR2 Channels by Cardiac Calsequestrin
Marcia Cortes-Gutierrez1, Heather R. Orrell1, Simon Williams2,
Patricio Velez1, Ariel L. Escobar1.
1UC Merced, Merced, CA, USA, 2TTUHSC, Lubbock, TX, USA.
We examined the hypothesis that calsequestrin (CSQ2) can regulate the RyR2
activity using a combination of single channel electrophysiology and lantha-
nide resonance energy transfer (LRET). Under steady-state, open probability
(Po) of RyR2 of cardiac SR fractions from dog is modulated by luminal
[Ca2þ]. Po increased when luminal [Ca2þ] was increased from 6 mM to
2 mM at a fixed cytosolic [Ca2þ] of 2 mM. This effect on RyR2 appears to
be mediated by luminal sites. Interestingly, RyR2 Po also increases when
2 mM Mg2þ was added to the luminal side. To gain mechanistic insights on
the Casq2-mediated luminal regulation, we used the binding of Casq2 to
Tbþ3 as a functional assay. Luminescence produced by LRET between the
tryptophan’s of purified dog Casq2 and the lanthanide increased as function
of the [Tbþ3]. This fluorescence was reduced as [Ca2þ] increased suggesting
that Ca2þ binds to purified Casq2 by displacing tightly bound Tbþ3 from
a common binding site. To further explore the specificity of this regulation,
we expressed recombinant dog Casq2 in E coli. The specificity of this interac-
tion was assessed by LRET lifetime measurements. Interestingly, we found that
the displacement of Tb3þ by Ca2þ was not significantly different than the dis-
placement of Tb3þ by Mg2þ (~ 2.5 mM) suggesting that Ca2þ and Mg2þ
share a common binding site. Finally, we explore the hypothesis that Tb3þ
bound to Casq2 was able to modulate the RR2 activity. At fixed cytosolic
[Ca2þ] of 2 mM, Po of single RyR2 increased as a function of luminal
[Tbþ3 (KD ~ 500 nM, Hill coeff. ~4). These results are consistent with the
idea that a multimeric form of Casq2 acts as luminal divalent cation sensor
and translates it into changes in RyR2 gating. Supported by NIH R01-HL-
084487 to AE.
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USA.CaMKII has been shown to increase cardiac SR Ca leak through RyRs. RyR2-
S2814 has been suggested as the phosphorylation site responsible for SR Ca
leak triggering cardiac arrhythmias in heart failure. Here we test the require-
ment of S2814 for these effects, in knock-in mice expressing only RyR2-
S2814A or -S2814D. Ca spark frequency (CaSpF) and SR load were studied
in intact and permeabilized cardiomyocytes using confocal microscopy. At
baseline CaSpF is higher in S2814D vs. WT (8.750.4 (n=9) vs 6.4450.3,
n¼8, p<0.01) without altered SR Ca load. Activation of endogenous CaMKII
(1.2 mM Ca-calmodulin) in WT increases CaSpF as described by Guo et al
(Circ. Res, 2006), but only to the level seen in S2814D at baseline. Moreover,
CaMKII did not further increase CaSpF in S2814D myocytes. In RyR2-
S2814A CaMKII activation produces a very small CaSpF increase vs WT
(19 vs 60%), and that response in S2814A is secondary to increased SR Ca
load (by 15%, n¼10, p<0.01). In intact myocytes (as above), basal CaSpF
was highest in S2814D vs. WT and S2814A (which were similar). Baseline
Ca transients were not different among the groups. The cAMP activated GTP
exchange factor Epac may activate CaMKII to induce SR Ca leak (Pereira
et al, J Physiol, 2007). In WT mice the Epac activator 8-CPT enhanced CaSpF
and decreased both SR Ca load and Ca transient amplitude (consistent with
a primary effect on SR Ca leak). However, 8-CPT had no effect on any of these
parameters in either S2814A or S2814D myocytes. These data indicate that
RyR2-S2814 is the critical RyR2 site responsible for CaMKII-dependent en-
hancement of SR Ca leak and potential arrhythmogenesis in heart failure,
and confirm that Epac signaling can work through this same pathway.
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Naturally occurring mutations in the cardiac Ca2þ release channel/ryanodine
receptor (RyR2) have been linked not only to cardiac arrhythmias and sudden
death, but also to cardiomyopathies. The causal mechanisms underlying RyR2-
associated cardiomyopathies are unknown. We have previously shown that
RyR2 mutations linked to catecholaminergic polymorphic ventricular tachycar-
dia (CPVT) reduce the threshold for store overload induced Ca2þ release
(SOICR), also known as spontaneous Ca2þ release during Ca2þ overload.
To determine the impact of RyR2 mutations associated with cardiomyopathies,
we generated stable, inducible HEK293 cells expressing the RyR2 wt and the
exon-3 deletion, R420W, and L433P mutants, and monitored the luminal Ca2þ
dynamics in these wt and mutant cells using the fluorescence resonance energy
transfer (FRET)-based luminal Ca2þ sensing protein, D1ER. Consistent with
other CPVT mutations, the exon-3 deletion, R420W, and L433P mutations re-
duce the SOICR threshold. Interestingly, we found that these mutations also
lower the critical luminal Ca2þ level at which Ca2þ release is terminated
(the termination threshold). To further assess the role of the NH2-terminal re-
gion of RyR2 in Ca2þ release termination, we deleted the first NH2-terminal
305 amino acid residues and found that this NH2-terminal deletion also lowers
the termination threshold for Ca2þ release. Our data demonstrate that the NH2-
terminal region of RyR2 plays an important role in Ca2þ release termination,
and suggest that alterations in the termination of Ca2þ release via RyR2 may
cause cardiomyopathies (Supported by NIH and CIHR).
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The neuropeptides oxytocin (OT) and vasopressin (AVP) are contained in large
dense core vesicles (LDCV) and are released at the neurohypophysis (NH). The
mobilization and translocation of vesicles to exocytotic release sites is modu-
lated by cytosolic Ca2þ. Intracellular structures and organelles able to store
and release Ca2þ are significant contributors of cytosolic Ca2þ. The presence
of ryanodine receptors (RyR) in LDCV of NH terminals, coupled with the dem-
onstration that pharmacological activation of these receptors can induce spon-
taneous focal Ca2þ transients, make them ideal modulators of cytosolic levels
of Ca2þ, and therefore, vesicle mobilization and subsequent neuropeptide (NP)
release.
To test this hypothesis, the association of LDCV in an area within 0.45 mm of
the plasma membrane was assessed using immunolabeling of Neurophysin I
(OT) and II (AVP) along with high stringency deconvolution techniques in iso-
lated NH terminals. We found that the total amount of membrane associated
NP-immunoreactivity varies significantly between terminal type; significantly
higher in OT than in AVP terminals. This membrane associated distribution
